Author:
Brenneman Douglas E.,Pearce David A.,Kovacs Attila,DeFrees Shawn
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Reference29 articles.
1. Brenneman DE, Smith GR, Zhang Y, Du Y, Kondaveeti SK, Zdilla MJ, Reitz AB (2012) Small-molecule anticonvulsant agents with potent in vitro neuroprotection. J Mol Neurosci 47:368–379
2. Cao Y, Staropoli JF, Biswas S, Espinola JA, MacDonald ME, Lee JM, Cotman SL (2011) Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS One 6:e17118
3. Cotman SL, Vrbanac V, Lebel LA, Lee RI, Johnson KA, Donahue LR, Teed AM, Antonelliks K, Bronson RT, Lerner TJ, MacDonald ME (2002) Cln3 (Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11:2709–2721
4. Dunn WA, Raizada MK, Vogt ES, Brown EA (1994) Growth factor-induced neurite growth in primary neuronal cultures of dogs with neuronal ceroid lipofuscinosis. Int J Dev Neurosci 12:185–196
5. El Chebib H, Harati H, Noutsi B, Rusyn E, Cotman S, Boustany R-M (2012) Exogenous galactosylceramide corrects growth and apoptotoic defects in human CLN3-deficient cells and behavioral deficis in CLN3Δex7/8 knock-in male mice by lowering ceramide. First Worldwide Meeting of the Batten Disease Alliance (BDIA), March 28–31
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献